| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.03 |
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | 0.072 | 0.03 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | 0.067 | 0.03 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | 0.072 | 0.04 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.04 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.04 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.093 | 0.05 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.085 | 0.05 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.05 |